Utilizing BRCA1/2 mutation status to select patients for breast cancer clinical trials: Experience from a prospective phase II trial. Background: Most inherited predisposition to breast cancer is ...
Association of PIK3CA-activating mutations with more disseminated disease at presentation and earlier recurrence in glioblastoma. Whole brain radiation therapy (WBRT) with or without oral topotecan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback